Phase II trial of dose-dense doxorubicin plus gemcitabine followed by paclitaxel plus carboplatin in patients with advanced urothelial carcinoma and impaired renal function.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples